| MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients (NCT02623933) | Sunnybrook Health Sciences Centre | 2015-09-24 |
| An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors (NCT04993261) | M.D. Anderson Cancer Center | 2015-09-23 |
| Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer (NCT02397083) | M.D. Anderson Cancer Center | 2015-09-23 |
| Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC (NCT03070366) | Groupe Oncologie Radiotherapie Tete et Cou | 2015-09-21 |
| OCS Heart EXPAND + CAP Continued Follow-Up (NCT05096299) | TransMedics | 2015-09-16 |
| Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study (NCT02184013) | Ottawa Heart Institute Research Corporation | 2015-09-14 |
| Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma (NCT02224781) | National Cancer Institute (NCI) | 2015-09-08 |
| Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer (NCT02664883) | University of Southern California | 2015-09-08 |
| Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome (NCT02530463) | M.D. Anderson Cancer Center | 2015-09-08 |
| Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems (NCT02314702) | MicroPort Orthopedics Inc. | 2015-09-04 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
| Characterization of Potential Biomarkers of Eye Disease and Vision (NCT02500862) | Association for Innovation and Biomedical Research on Light and Image | 2015-09-01 |
| Curative Chemoradiation of Low Rectal Cancer (NCT02438839) | Vejle Hospital | 2015-09-01 |
| Self-management in Patients With Adrenal Insufficiency. (NCT06637722) | Region Stockholm | 2015-09-01 |
| Pilot Study on Mindfulness Based Stress Reduction (MBSR) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT07593521) | Université Libre de Bruxelles | 2015-09-01 |
| Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia (NCT02965638) | Shaine Morris | 2015-09-01 |
| Bypass Equipoise Sleeve Trial (BEST) (NCT02767505) | Göteborg University | 2015-09-01 |
| HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors (NCT02875314) | Parth Patel | 2015-09-01 |
| Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™ (NCT02380092) | Smith & Nephew, Inc. | 2015-09-01 |
| Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation (NCT03625349) | VA Office of Research and Development | 2015-09-01 |
| A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML) (NCT02483312) | University Health Network, Toronto | 2015-09-01 |
| PET-MR-PSA Prostate Cancer Recidive Study (NCT02562131) | Norwegian University of Science and Technology | 2015-09-01 |
| Finnish Unicompartmental and Total Knee Arthroplasty Investigation (NCT02481427) | Turku University Hospital | 2015-09-01 |
| Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery (NCT02466737) | University of Rostock | 2015-09-01 |
| The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability (NCT02510625) | Nova Scotia Health Authority | 2015-09-01 |
| JOURNEY™ II CR Total Knee System (NCT02440672) | Smith & Nephew, Inc. | 2015-09-01 |
| Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation (NCT03119584) | Texas Tech University Health Sciences Center, El Paso | 2015-09-01 |
| Efficacy of a Modified Technique of Free Gingival Graft in Volumetric Changes of the Graft: Randomized Clinical Trial (NCT02613702) | University of Sao Paulo | 2015-09-01 |
| Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking (NCT02514512) | Royal North Shore Hospital | 2015-09-01 |
| Lenalidomide Maintenance in Plasma Cell Myeloma (NCT02538198) | Memorial Sloan Kettering Cancer Center | 2015-08-31 |
| Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma (NCT02537548) | University of Southern California | 2015-08-28 |
| Resistive Training Combined With Nutritional Therapy After Stroke (NCT02347995) | VA Office of Research and Development | 2015-08-24 |
| Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer (NCT02530177) | Memorial Sloan Kettering Cancer Center | 2015-08-19 |
| Urinary Biomarkers of OI Pathobiology (NCT02531087) | Baylor College of Medicine | 2015-08-17 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Donor Specific HLA Alloantibodies in Liver Transplantation (NCT02784080) | Rigshospitalet, Denmark | 2015-08-15 |
| Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer (NCT02522715) | OHSU Knight Cancer Institute | 2015-08-13 |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer (NCT02491632) | M.D. Anderson Cancer Center | 2015-08-13 |
| Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B) (NCT04439136) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q) (NCT04439110) | National Cancer Institute (NCI) | 2015-08-12 |
| Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response (NCT03373552) | Hôpital Universitaire Fattouma Bourguiba | 2015-08-12 |
| Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G) (NCT04439253) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F) (NCT04439266) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R) (NCT04439279) | National Cancer Institute (NCI) | 2015-08-12 |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors (NCT02375204) | Alliance for Clinical Trials in Oncology | 2015-08-06 |
| Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer (NCT02515110) | Virginia Commonwealth University | 2015-08-04 |
| Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer (NCT02517034) | City of Hope Medical Center | 2015-08-04 |
| Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia (NCT02427451) | Kerry Rogers | 2015-08-03 |
| The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil (NCT02530697) | University of Brasilia | 2015-08-01 |
| Pilot Study of The EPIC Trial (NCT02533206) | Ottawa Hospital Research Institute | 2015-08-01 |
| Lenalidomide for Adult Histiocyte Disorders (NCT02523040) | Dana-Farber Cancer Institute | 2015-08-01 |
| Zambian Preterm Birth Prevention Study (NCT02738892) | University of North Carolina, Chapel Hill | 2015-08-01 |
| Triathlon Tritanium Cone Augments Outcomes Study (NCT02521103) | Stryker Orthopaedics | 2015-08-01 |
| A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (NCT02238808) | AHS Cancer Control Alberta | 2015-08-01 |
| Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH) (NCT02710968) | Johns Hopkins University | 2015-08-01 |
| Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors (NCT02498912) | Memorial Sloan Kettering Cancer Center | 2015-08-01 |
| PALbociclib CoLlaborative Adjuvant Study (NCT02513394) | Alliance Foundation Trials, LLC. | 2015-08-01 |
| Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite (NCT02427698) | Northwestern University | 2015-08-01 |
| Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection (NCT02523443) | Memorial Sloan Kettering Cancer Center | 2015-08-01 |
| A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes (NCT03057730) | Tufts University | 2015-08-01 |
| Effects of the Herbst Appliance With Different Anchorages and Twin-Block Appliance in Class II Malocclusion (NCT02411812) | Klaus Barretto-Lopes | 2015-08-01 |
| Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study) (NCT02572934) | University Medical Center Groningen | 2015-08-01 |
| Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma (NCT02446457) | M.D. Anderson Cancer Center | 2015-07-31 |
| Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL) (NCT02477696) | Acerta Pharma BV | 2015-07-28 |
| Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer (NCT02488967) | NRG Oncology | 2015-07-26 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208) | National Cancer Institute (NCI) | 2015-07-22 |
| Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia (NCT02339740) | Children's Oncology Group | 2015-07-21 |
| Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) (NCT02453282) | AstraZeneca | 2015-07-21 |
| MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) (NCT02422381) | Providence Health & Services | 2015-07-20 |
| Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) (NCT02393794) | Priyanka Sharma | 2015-07-17 |
| Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054) (NCT02362594) | Merck Sharp & Dohme LLC | 2015-07-16 |
| Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas (NCT02503423) | Taiho Oncology, Inc. | 2015-07-14 |
| Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment (NCT02460133) | Nova Scotia Health Authority | 2015-07-10 |
| ASPirin Intervention for the REDuction of Colorectal Cancer Risk (NCT02394769) | Massachusetts General Hospital | 2015-07-06 |
| A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies (NCT02494986) | Janssen Sciences Ireland UC | 2015-07-06 |
| Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma (NCT02494700) | M.D. Anderson Cancer Center | 2015-07-06 |
| Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT02420847) | M.D. Anderson Cancer Center | 2015-07-03 |
| Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial (NCT02275533) | National Cancer Institute (NCI) | 2015-07-02 |
| Patients Navigators in Facilitating Weight Management in Obese Participants (NCT03674229) | M.D. Anderson Cancer Center | 2015-07-02 |
| CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) (NCT04116047) | University of Birmingham | 2015-07-01 |
| Re-irradiation of Recurrent Head and Neck Cancer (NCT01973179) | Technische Universität Dresden | 2015-07-01 |
| The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR (NCT02493582) | The First People's Hospital of Changzhou | 2015-07-01 |
| Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia (NCT02549820) | Children's Hospital of Philadelphia | 2015-07-01 |
| EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors (NCT01591356) | M.D. Anderson Cancer Center | 2015-07-01 |
| Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing (NCT02525406) | University of Toledo Health Science Campus | 2015-07-01 |
| A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) (NCT02099123) | Monash University | 2015-07-01 |
| Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer (NCT02494869) | Memorial Sloan Kettering Cancer Center | 2015-07-01 |
| The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer (NCT02487992) | The First People's Hospital of Changzhou | 2015-07-01 |
| Micra Transcatheter Pacing System Post-Approval Registry (NCT02536118) | Medtronic | 2015-07-01 |
| Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer (NCT02490748) | The First People's Hospital of Changzhou | 2015-07-01 |
| Network Analysis of Urinary Molecular Signature Complements Clinical Data to Predict Postoperative Acute Kidney Injury (NCT02114138) | University of Florida | 2015-07-01 |
| Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma (NCT02487693) | The First People's Hospital of Changzhou | 2015-07-01 |
| Randomized Controlled Trial Examining Health Care Access Interventions for Taxi Drivers (NCT02508363) | Memorial Sloan Kettering Cancer Center | 2015-07-01 |
| Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma (NCT02502786) | Memorial Sloan Kettering Cancer Center | 2015-07-01 |
| Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS) (NCT02487966) | Spaulding Rehabilitation Hospital | 2015-07-01 |
| LEGION Hinge Safety and Efficacy Study (NCT02445443) | Smith & Nephew, Inc. | 2015-06-30 |
| Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia (NCT02143414) | National Cancer Institute (NCI) | 2015-06-30 |
| Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older (NCT02494882) | Memorial Sloan Kettering Cancer Center | 2015-06-29 |
| Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... (NCT02484404) | National Cancer Institute (NCI) | 2015-06-29 |
| Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL (NCT02475681) | Acerta Pharma BV | 2015-06-26 |